Literature DB >> 9620417

Low-level vancomycin resistance in Clostridium innocuum.

F Mory1, A Lozniewski, V David, J P Carlier, L Dubreuil, R Leclercq.   

Abstract

Low-level vancomycin resistance was observed for 28 clinical Clostridium innocuum isolates and C. innocuum NCIB 10674, whereas teicoplanin was active. DNA from three clinical isolates and the type strain could not be amplified by PCR with primers specific for the genes vanA, vanB, and vanC, suggesting that C. innocuum is intrinsically resistant to vancomycin.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9620417      PMCID: PMC104917     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  9 in total

1.  Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR.

Authors:  S Dutka-Malen; S Evers; P Courvalin
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

2.  Problems with the disk diffusion test for detection of vancomycin resistance in enterococci.

Authors:  J M Swenson; B C Hill; C Thornsberry
Journal:  J Clin Microbiol       Date:  1989-09       Impact factor: 5.948

3.  Evaluation of teicoplanin and vancomycin disk susceptibility tests.

Authors:  A L Barry; C Thornsberry; R N Jones
Journal:  J Clin Microbiol       Date:  1986-01       Impact factor: 5.948

4.  Towards a phylogeny of the clostridia based on 16S rRNA sequences.

Authors:  P A Lawson; P Llop-Perez; R A Hutson; H Hippe; M D Collins
Journal:  FEMS Microbiol Lett       Date:  1993-10-01       Impact factor: 2.742

5.  In vitro activity of teicoplanin and vancomycin against anaerobes.

Authors:  Y Glupczynski; M Labbe; F Crokaert; E Yourassowsky
Journal:  Eur J Clin Microbiol       Date:  1984-02       Impact factor: 3.267

6.  Identification and antimicrobial resistance patterns of clinical isolates of Clostridium clostridioforme, Clostridium innocuum, and Clostridium ramosum compared with those of clinical isolates of Clostridium perfringens.

Authors:  C J Alexander; D M Citron; J S Brazier; E J Goldstein
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

Review 7.  Clostridium innocuum endocarditis.

Authors:  A F Cutrona; C Watanakunakorn; C R Schaub; A Jagetia
Journal:  Clin Infect Dis       Date:  1995-11       Impact factor: 9.079

8.  The phylogeny of the genus Clostridium: proposal of five new genera and eleven new species combinations.

Authors:  M D Collins; P A Lawson; A Willems; J J Cordoba; J Fernandez-Garayzabal; P Garcia; J Cai; H Hippe; J A Farrow
Journal:  Int J Syst Bacteriol       Date:  1994-10

9.  In vitro and in vivo evaluation of A-56268 (TE-031), a new macrolide.

Authors:  P B Fernandes; R Bailer; R Swanson; C W Hanson; E McDonald; N Ramer; D Hardy; N Shipkowitz; R R Bower; E Gade
Journal:  Antimicrob Agents Chemother       Date:  1986-12       Impact factor: 5.191

  9 in total
  7 in total

1.  Clostridium clostridioforme: a mixture of three clinically important species.

Authors:  S M Finegold; Y Song; C Liu; D W Hecht; P Summanen; E Könönen; S D Allen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-05       Impact factor: 3.267

2.  Distinct Functional Metagenomic Markers Predict the Responsiveness to Anti-PD-1 Therapy in Chinese Non-Small Cell Lung Cancer Patients.

Authors:  Chao Fang; Wenfeng Fang; Liqin Xu; Fangfang Gao; Yong Hou; Hua Zou; Yuxiang Ma; Janne Marie Moll; Yunpeng Yang; Dan Wang; Yan Huang; Huahui Ren; Hongyun Zhao; Shishang Qin; Huanzi Zhong; Junhua Li; Sheng Liu; Huanming Yang; Jian Wang; Susanne Brix; Karsten Kristiansen; Li Zhang
Journal:  Front Oncol       Date:  2022-04-21       Impact factor: 5.738

3.  Mechanism of intrinsic resistance to vancomycin in Clostridium innocuum NCIB 10674.

Authors:  Véronique David; Bülent Bozdogan; Jean-Luc Mainardi; Raymond Legrand; Laurent Gutmann; Roland Leclercq
Journal:  J Bacteriol       Date:  2004-06       Impact factor: 3.490

4.  Clostridium innocuum Bacteremia in a patient with acquired immunodeficiency syndrome.

Authors:  Nancy Crum-Cianflone
Journal:  Am J Med Sci       Date:  2009-06       Impact factor: 2.378

5.  Distant myonecrosis by atraumatic Clostridium septicum infection in a patient with metastatic breast cancer.

Authors:  Kelsey M Gray; Pablo L Padilla; Blake Sparks; Peter Dziewulski
Journal:  IDCases       Date:  2020-05-05

Review 6.  Clostridium innocuum: Microbiological and clinical characteristics of a potential emerging pathogen.

Authors:  Kathryn E Cherny; Emily B Muscat; Megan E Reyna; Larry K Kociolek
Journal:  Anaerobe       Date:  2021-07-28       Impact factor: 3.331

7.  Osteomyelitis due to Clostridium innocuum in a patient with acute lymphoblastic leukemia: case report and literature review.

Authors:  Yoshikazu Mutoh; Risen Hirai; Akira Tanimura; Takashi Matono; Eriko Morino; Satoshi Kutsuna; Maki Nagamatsu; Norio Ohmagari; Shotaro Hagiwara
Journal:  Springerplus       Date:  2015-07-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.